Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Science Ho Chi Minh City
With
Van Hanh General Hospital
Nguyen Tri Phuong Hospital, Ho Chi Minh city, Viet Nam
GeneWorld Ltd Co, Ho Chi Minh city, Viet Nam
Age
40–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age 40 to 80, inclusive
A prior diagnosis of moderate to severe COPD
GOLD IIa, III, IV
You may not be if
Pregnant or lactating
Life expectancy \< 6 months due to concomitant illnesses.
Exposure to any investigational drug or procedure within 1 month prior to study entry or enrolled in a concurrent study that may confound results of this study.
Any illness which, in the Investigators judgment, will interfere with the patient's ability to comply with the protocol, compromise patient safety, or interfere with the interpretation of study results
Subjects on chronic immunosuppressive or chemotherapeutic therapy
Known drug or alcohol dependence or any other factors which will interfere with the study conduct or interpretation of the results or who in the opinion of the investigator are not suitable to participate.
Subjects with Alpha-1 antitrypsin deficiency (an inherited disorder that can cause lung disease and liver disease).
Unwilling and/or not able to give written consent
Patient is positive for hepatitis (past history of Hepatitis A is allowed)
Any medical condition, which in the opinion of the clinical investigator, would interfere with the treatment or outcome of the patient
